Clinishield Hand Hygiene Infection Control

View Product Sheet (pdf)
View English MSDS (pdf)
View French MSDS (pdf)
View French MSDS (pdf)

Select another Clinishield^® Product:

CliniShield^® Healthcare Personnel Handwash

Anextremely mild yet highly effective antimicrobial handwash with 1% Triclosan for use before and after clinical contact.
Dermatologist tested formula designed for use on all skin types.
Demonstratesa greater than 99% kill in 15 seconds or less against the antibiotic resistant bacteria MRSA and VRE.
The anti-bacterial efficacy of Clinishield Health Care Personnel Handwash is demonstrated in both in-vitro and in-vivo testing as specified by the FDA “TFM for Health Care Antiseptic Drug Products”. Effective against a broad spectrum of organisms associated with the most commonly occurring healthcare acquired infections including those listed in the “National Nosocomial Infection Surveillance (NNIS) System Report”.

1.	“Tentative Final Monograph for Health Care Antiseptic Drug Products,” Federal Register, Vol. 59, No. 116, p. 31444.
2.	"National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990 - May 1999, issued June 1999," American Journal of Infection Control, Vol. 27, No. 6, pp. 520-535.

Stock #	Size	#/Case
64107	16 fl. oz. w/ pump	12 bottles/case
64106	1600 ml bottle	6 bottles/case

Physical Properties:

Description: yellow, clear liquid
Fragrance: pleasant, mild, non-lingering
pH: 5.3 - 6.3
Viscosity: 2,000 - 4,000

Efficacy Tests
Minimum Inhibitory Concentration (MIC) (In Vitro)
Purpose: To determine the concentration of an antiseptic handwash which will inhibit the growth of bacteria.

Time Kill (In Vitro)
Purpose: To measure the ability of an antiseptic handwash to reduce bacteria at different points of time exposure, e.g. 15 or 30 seconds.

Health Care Personnel Handwash Test (In Vivo)
Purpose: To determine the ability of an antiseptic handwash to reduce bacteria on the hands after an actual handwash procedure using the marker organism (Serratia marcesans). FDA defines an antiseptic handwash as one which provides a greater than 99% reduction of the marker organism after a single handwash and a greater than 99.9% reduction after the 10th handwash.

15 Second Time Kill / MIC

Microorganisms	Source	Time Kill (In Vitro)	MIC (In Vitro)
Bacterial Strains
Acinetobacter baumannii	ATCC 19606	98.6	>1:2048
Clostridium difficile (vegetative)	ATCC 9689	>99.8	>1:2048
Escherichia coli	ATCC 11229	99.5	>1:2048
Enterobacter aerogenes	ATCC 13048	99.8	>1:2048
Enterococcus faecalis	ATCC 29212	99.6	>1:2048
Klebsiella pneumonia	ATCC 11296	99.8*	>1:2048
Proteus mirabilis	ATTC 9240	96.0*	>1:2048
Pseudomonas aeruginosa	ATCC 9027	99.7	1:8
Staphylococcus aureus	ATCC 6538	99.6	>1:2048
Staphylococcus epidermidis	ATCC 12228	98.4*	>1:2048
Antibiotic Resistant Bacterial Strains
Enterococcus faecium VRE	ATCC 51559	>99.9	>1:2048
Haemophilus influenzae	ATCC 19418	99.9	>1:2048
Serratia marcescens	ATCC 8100	99.3*	>1:2048
Staphylococcus aureus MRSA	ATCC 33593	99.6	>1:2048
Streptococcus pneumoniae	ATCC 6303	99.5*	>1:2048

ATCC - American Type Culture Collection *30 Second Exposure

Healthcare Personnel Handwash Test
CliniShield vs. Leading Chloroxylenol Containing Antiseptic Handwash

Product	After Wash #1	After Wash #10
CliniShield^® Healthcare Personnel Handwash	Log₁₀ 2.8655 (99.86%)	Log₁₀ 3.1782 (99.93%)
Leading Antiseptic Handwash With Chloroxylenol	Log₁₀ 2.40 (99.60%)	Log₁₀ 2.31 (99.51%)

(1, 2)

1 “Report For Efficacy Evaluation of a Liquid Health Care Personnel Handwash Product, Hilltop Research, Inc.
   Miamiville, OH. For Stockhausen, Inc.”
2 The Clinishield^® product met the FDA performance criteria of a greater than 99% reduction of the bacteria
  after the 1st handwash and a greater than 99.9% reduction after the 10th handwash, whereas the
   chloroxylenol containing product failed to do so.